Specimen Collection and Testing for
Seasonal Influenza

More information for health professionals regarding specimen collection, submission, and treatment for influenza.
Information for Health Professionals on Novel Influenza A Virus (H7N9) | Information For Health Professionals on Influenza A Variant Viruses H3N2v and H1N2v

On this page:
Appropriate Specimen Types
Specimen Submission Forms
Shipping to MDH-PHL
Additional Influenza Surveillance Programs
Reporting Influenza
Other Influenza Information

Please send a specimen to the MDH Public Health Laboratory (MDH-PHL) in the following circumstances:

  • Hospitalized surveillance – specimens submitted from persons who are hospitalized with ILI* or clinical suspicion of influenza or deceased following ILI* or clinical suspicion of influenza.
    • It is important to send a specimen on any hospitalized patient with ILI* or clinical suspicion of influenza; even if rapid influenza testing, PCR, and/or viral culture is negative or if testing was not performed.
    • Hospital laboratories have chosen two collection days per week when they will submit specimens. Each hospital laboratory should submit specimens on their chosen two days per week or a minimum of five specimens weekly. If two collection days do not result in more than five specimens, submit specimens daily during that week (including specimens collected on weekend days).
    • If your laboratory is performing onsite influenza testing by PCR, positive influenza A specimens that are subtyped as pdm H1 or H3 do not need to be routinely submitted.
      • Positive influenza A specimens that are unsubtyped, subtyped as “seasonal H1,” or “indeterminate” do need to be submitted to MDH-PHL for further characterization as they could be variant influenza strains.
      • All positive influenza B specimens should be submitted to MDH-PHL.
    • Specimens from deceased patients following confirmed or suspect influenza illness should be submitted for all patients, regardless of collection day.
  • Cluster investigation or other unusual circumstance for which MDH epidemiology has requested a specimen(s) be sent to MDH-PHL.
  • Sentinel surveillance – these facilities are pre-determined.
  • Laboratory surveillance - isolates from virology laboratories only.

Appropriate Specimen Types

For patients admitted with influenza like symptoms (ILI*) or clinical suspicion of influenza without evidence of pneumonia or other lower respiratory disease – submit one upper respiratory specimen per patient.

Preferred specimen:

  • Nasopharyngeal swab

Other acceptable specimens:

  • nasal swab
  • nasal wash/aspirate
  • throat swab
  • combined nasal swab with an oropharyngeal swab
  • viral culture

For patients admitted with ILI* or clinical suspicion of influenza who also have evidence of pneumonia or other lower respiratory disease, submit one upper respiratory specimen and one lower respiratory specimen (do not perform a procedure such as bronchoscopy solely for the purpose of collecting a specimen for testing by MDH-PHL) per patient.

Submit an upper respiratory specimen in addition to one or more of the following:

  • Bronchial alveolar lavage (BAL)
  • Tracheal aspirate (if intubated)
  • Bronchial wash

* ILI is defined as fever (measured or subjective) and cough or shortness of breath or difficulty breathing in the absence of a known disease other than influenza.

Specimen Collection

  • Store at refrigeration temperature until transport.
  • Freeze specimen if it will not reach MDH-PHL within 7 days.

Specimen Submission Forms

Only a single Clinical Testing and Submission Form is required; however, you must use the correct version of the form depending on whether the patient is hospitalized or not. Note: There is no fee sticker required for influenza testing.

Hospitalized Patients Only (Project #1492)
Use this form for all specimens submitted from persons hospitalized with ILI or clinical suspicion of influenza. To allow for prompt testing of submitted specimens for project #1492, please fill out the form completely, especially information regarding hospitalization (date of admission, hospital of admission, and outcome) found on the lower right hand corner of the form.

Non-Hospitalized Influenza Testing (Project #493)
This form should only be used if MDH staff specifically request specimens be submitted under project #493. Use this form for submitting specimens for influenza testing from non-hospitalized patients. Please indicate project #493 in the upper right hand corner of the form.

Shipping to MDH-PHL

  • Ship specimens to MDH-PHL by an overnight delivery service.
    Note: It is the responsibility of the submitting laboratory to determine the appropriate packaging and shipping for patient specimens and culture isolates. See U.S. Department of Transportation Regulations for more information. Attention: Non-MDH link
  • Use cold packs to keep specimens at 4 degrees C, or dry ice if specimen is frozen.
  • Ship to:

Minnesota Department of Health
Public Health Laboratory
Attn: Biological Accessioning
601 Robert St. N
St. Paul, Minnesota 55155-2531

Additional Influenza Surveillance Programs

MLS Laboratory Influenza Surveillance Program
MDH Weekly Influenza Activity - Statistics
The MN Lab System (MLS) Laboratory Influenza Surveillance Program is made up of more than 100 clinic- and hospital-based laboratories, voluntarily submitting testing data on a weekly basis. These laboratories perform rapid testing (DFA, rapid EIA) for Influenza and Respiratory Syncytial Virus (RSV). Significantly fewer labs, perform confirmatory culture testing for Influenza and RSV, and even fewer perform PCR.

Tracking the laboratory results assists healthcare providers with patient diagnosis of influenza-like illness and provides an indicator as to the progression of the influenza season as well as prevalence of disease in the community.

If your laboratory is interested in participating in this program, please call: 651-201-5580

MLS Virology Laboratory Isolate Surveillance
Viral isolates are subtyped to monitor for the introduction of new influenza virus strains for comparison to the current vaccine subtypes. MDH-PHL performs hemagglutinin subtyping on isolates submitted from virology laboratories serving MN patients. Selected influenza isolates are forwarded to CDC for neuraminidase subtyping.

U.S. Outpatient Influenza-like Illness Surveillance Network (ILINet)
Physicians and health care providers across the state help to monitor influenza throughout the flu season. ILINet providers fill out a weekly report detailing the number of patients they've seen with influenza-like illness. They also submit additional influenza specimens to the MDH-PHL according to the ILINet program guidelines.

Novel Influenza A Surveillance
Call MDH at 651-201-5414 or 1-877-676-5414 if you have a suspect novel influenza A. Do not attempt to perform viral culture. Culture for novel influenza should only be done at a BSL3+ or BSL4 facility.

Reporting Influenza

Reporting Influenza - information on what to report, how to report, and who is required to report.


  • For an MDH epidemiologist, call 651-201-5414 or 1-877-676-5414.
  • During business hours you can call the Virology Supervisor at 651-201-5255.

More information for health professionals regarding specimen collection, submission, and treatment for influenza.
Seasonal Flu Information for Health Professionals | Information For Health Professionals on Influenza A Variant Viruses H3N2v and H1N2v

Updated Tuesday, October 20, 2015 at 04:47PM